Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 45.11%409.8M | 54.26%373.3M | 67.86%351M | 33.74%1.08B | 69.07%346.6M | 37.96%282.4M | 23.47%242M | 3.57%209.1M | 25.95%807.6M | 10.16%205M |
| Operating revenue | 45.11%409.8M | 54.26%373.3M | 67.86%351M | 33.74%1.08B | 69.07%346.6M | 37.96%282.4M | 23.47%242M | 3.57%209.1M | 25.95%807.6M | 10.16%205M |
| Cost of revenue | 45.96%301.7M | 58.42%278.5M | 79.43%271.3M | 41.66%798.4M | 79.82%264.7M | 40.61%206.7M | 30.51%175.8M | 12.25%151.2M | 36.53%563.6M | 15.72%147.2M |
| Gross profit | 42.80%108.1M | 43.20%94.8M | 37.65%79.7M | 15.45%281.7M | 41.70%81.9M | 31.20%75.7M | 7.99%66.2M | -13.84%57.9M | 6.83%244M | -1.87%57.8M |
| Operating expense | 86.57%75M | 16.10%51.2M | 3.98%44.4M | 5.05%174.9M | 14.59%47.9M | -4.29%40.2M | 5.00%44.1M | 4.91%42.7M | 8.26%166.5M | 4.50%41.8M |
| Selling and administrative expenses | 54.67%33.1M | 41.35%33.5M | 27.57%27.3M | 12.76%91M | 13.43%24.5M | 3.88%21.4M | 14.49%23.7M | 20.22%21.4M | 17.81%80.7M | 11.34%21.6M |
| -Selling and marketing expense | 19.28%9.9M | 86.21%16.2M | 11.24%9.9M | 5.72%35.1M | 21.05%9.2M | 2.47%8.3M | -13.86%8.7M | 20.27%8.9M | 32.27%33.2M | 15.15%7.6M |
| -General and administrative expense | 77.10%23.2M | 15.33%17.3M | 39.20%17.4M | 17.68%55.9M | 9.29%15.3M | 4.80%13.1M | 41.51%15M | 20.19%12.5M | 9.45%47.5M | 9.38%14M |
| Research and development costs | 65.28%11.9M | -31.82%6M | -38.89%5.5M | -6.11%36.9M | 40.00%11.9M | -30.77%7.2M | -14.56%8.8M | -10.89%9M | 19.82%39.3M | 8.97%8.5M |
| Depreciation amortization depletion | 158.62%30M | 0.86%11.7M | -5.69%11.6M | 1.08%47M | -1.71%11.5M | 5.45%11.6M | 5.45%11.6M | -3.91%12.3M | -11.43%46.5M | -8.59%11.7M |
| -Depreciation and amortization | 158.62%30M | 0.86%11.7M | -5.69%11.6M | 1.08%47M | -1.71%11.5M | 5.45%11.6M | 5.45%11.6M | -3.91%12.3M | -11.43%46.5M | -8.59%11.7M |
| Operating profit | -6.76%33.1M | 97.29%43.6M | 132.24%35.3M | 37.81%106.8M | 112.50%34M | 126.11%35.5M | 14.51%22.1M | -42.64%15.2M | 3.89%77.5M | -15.34%16M |
| Net non-operating interest income (expenses) | -76.19%-3.7M | 108.33%600K | 40.74%-3.2M | -218.18%-21M | -6,400.00%-6.3M | 12.50%-2.1M | -242.86%-7.2M | -145.45%-5.4M | 64.89%-6.6M | -99.21%100K |
| Non-operating interest income | -17.39%1.9M | 400.00%3.5M | 142.86%1.7M | 250.00%7M | 94.12%3.3M | 666.67%2.3M | 133.33%700K | 133.33%700K | 400.00%2M | --1.7M |
| Non-operating interest expense | 27.27%5.6M | -63.29%2.9M | -19.67%4.9M | 225.58%28M | 500.00%9.6M | 62.96%4.4M | 229.17%7.9M | 144.00%6.1M | -36.30%8.6M | 108.94%1.6M |
| Other net income (expenses) | 30.56%9.4M | -2,000.00%-8.4M | 36.08%13.2M | 800.00%25.2M | 422.22%8.7M | 350.00%7.2M | 83.33%-400K | 9,800.00%9.7M | 83.33%-3.6M | 85.00%-2.7M |
| Gain on sale of security | 16.67%8.4M | -1,580.00%-8.4M | 312.50%13.2M | 619.44%18.7M | 425.93%8.8M | 350.00%7.2M | 79.17%-500K | 3,300.00%3.2M | 41.94%-3.6M | -3.85%-2.7M |
| Special income (charges) | ---- | ---- | ---- | --5.8M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --5.8M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | --1M | ---- | ---- | --700K | ---5.9M | ---- | --100K | --6.5M | ---- | ---- |
| Income before tax | -4.43%38.8M | 146.90%35.8M | 132.31%45.3M | 64.93%111M | 171.64%36.4M | 172.48%40.6M | -2.03%14.5M | -19.42%19.5M | 96.78%67.3M | -0.74%13.4M |
| Income tax | 29.73%14.4M | 145.71%8.6M | 117.54%12.4M | 70.81%31.6M | 11,400.00%11.3M | 98.21%11.1M | -28.57%3.5M | -29.63%5.7M | 134.18%18.5M | -102.13%-100K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -17.29%24.4M | 147.27%27.2M | 138.41%32.9M | 62.70%79.4M | 85.93%25.1M | 217.20%29.5M | 11.11%11M | -14.29%13.8M | 85.55%48.8M | 53.41%13.5M |
| Net income continuous operations | -17.29%24.4M | 147.27%27.2M | 138.41%32.9M | 62.70%79.4M | 85.93%25.1M | 217.20%29.5M | 11.11%11M | -14.29%13.8M | 85.55%48.8M | 53.41%13.5M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -17.29%24.4M | 147.27%27.2M | 138.41%32.9M | 62.70%79.4M | 85.93%25.1M | 217.20%29.5M | 11.11%11M | -14.29%13.8M | 85.55%48.8M | 53.41%13.5M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -17.29%24.4M | 147.27%27.2M | 138.41%32.9M | 62.70%79.4M | 85.93%25.1M | 217.20%29.5M | 11.11%11M | -14.29%13.8M | 85.55%48.8M | 53.41%13.5M |
| Diluted earnings per share | -24.00%0.19 | 144.44%0.22 | 125.00%0.27 | 60.98%0.66 | 90.91%0.21 | 212.50%0.25 | 12.50%0.09 | -14.29%0.12 | 86.36%0.41 | 57.14%0.11 |
| Basic earnings per share | -20.83%0.19 | 133.33%0.21 | 136.36%0.26 | 57.50%0.63 | 72.73%0.19 | 200.00%0.24 | 12.50%0.09 | -15.38%0.11 | 90.48%0.4 | 57.14%0.11 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.